- Home
- CCRD vs AARD Comparison
CCRD vs AARD Comparison
Compare CCRD & AARD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CCRD
- AARD
- Stock Information
- Founded
- CCRD 1973
- AARD 2017
- Country
- CCRD United States
- AARD United States
- Employees
- CCRD N/A
- AARD N/A
- Industry
- CCRD
- AARD Biotechnology: Pharmaceutical Preparations
- Sector
- CCRD
- AARD Health Care
- Exchange
- CCRD Nasdaq
- AARD Nasdaq
- Market Cap
- CCRD 157.9M
- AARD 154.9M
- IPO Year
- CCRD N/A
- AARD 2025
- Fundamental
- Price
- CCRD $28.41
- AARD $11.13
- Analyst Decision
- CCRD Hold
- AARD Strong Buy
- Analyst Count
- CCRD 1
- AARD 4
- Target Price
- CCRD $21.00
- AARD $31.25
- AVG Volume (30 Days)
- CCRD 63.4K
- AARD 29.5K
- Earning Date
- CCRD 07-31-2025
- AARD 08-14-2025
- Dividend Yield
- CCRD N/A
- AARD N/A
- EPS Growth
- CCRD 187.14
- AARD N/A
- EPS
- CCRD 0.86
- AARD N/A
- Revenue
- CCRD $61,011,000.00
- AARD N/A
- Revenue This Year
- CCRD $17.35
- AARD N/A
- Revenue Next Year
- CCRD N/A
- AARD N/A
- P/E Ratio
- CCRD $33.31
- AARD N/A
- Revenue Growth
- CCRD 12.31
- AARD N/A
- 52 Week Low
- CCRD $11.57
- AARD $4.88
- 52 Week High
- CCRD $31.99
- AARD $19.58
- Technical
- Relative Strength Index (RSI)
- CCRD 63.78
- AARD N/A
- Support Level
- CCRD $28.41
- AARD N/A
- Resistance Level
- CCRD $31.99
- AARD N/A
- Average True Range (ATR)
- CCRD 1.29
- AARD 0.00
- MACD
- CCRD -0.18
- AARD 0.00
- Stochastic Oscillator
- CCRD 48.26
- AARD 0.00
About CCRD CoreCard Corporation
CoreCard Corp is engaged in the business of providing technology solutions and processing services to the financial technology and services market. It designs, develops and markets a comprehensive suite of software solutions to program managers, accounts receivable businesses, financial institutions, retailers and processors to manage their credit and debit cards, prepaid cards, private label cards, fleet cards, buy now pay later programs, loyalty programs and accounts receivable and loan transactions. The CoreCard software platform and modules include CoreENGINE, CoreISSUE, CoreFRAUD, CoreCOLLECT, CoreAPP, CoreMONEY and CoreACQUIRE. Its customers are located in the U.S, European Union and the Middle East of which key revenue is derived from the U.S.
About AARD Aardvark Therapeutics Inc. Common Stock
Aardvark Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing novel, small-molecule therapeutics to activate innate homeostatic pathways for the treatment of metabolic diseases. It is focused on on developing selective compounds, targeting Bitter Taste Receptors (TAS2Rs) for hunger-associated conditions. Its product candidate, ARD-101, is an oral gut-restricted small-molecule agonist of certain TAS2Rs expressed in the gut lumen for which have initiated a Phase 3 clinical trial for hyperphagia associated with PWS.